Literature DB >> 12601112

The epidemiology of ALS in Modena, Italy.

Jessica Mandrioli1, Pietro Faglioni, Elisa Merelli, Patrizia Sola.   

Abstract

OBJECTIVE: To determine the incidence, prevalence, and mortality rates of ALS in the province of Modena, Northern Italy, from 1990 through 1999.
METHODS: A retrospective epidemiologic study was conducted, ascertaining cases from all neurologic centers and hospitals of the province, death certificates, and the Italian ALS Association, section of Modena. All clinical records were reviewed, and only patients fulfilling the El Escorial revised diagnostic criteria were included.
RESULTS: During the period considered (1990 to 1999), 143 residents (67 men and 76 women) entered the study. The average annual incidence was 2.16 per 100,000, with a peak in the age class of 75 to 79 years. Mean prevalence rate was 4.02 per 100,000, and mean mortality rate was 1.69 per 100,000. The incidence rate remained constant over time, whereas the prevalence and mortality rates increased owing to a rise in survival time (ALS mean duration was 17.38 months in 1990, 43.18 months in 1999). In the mountainous areas, where agricultural work is more common, the incidence, prevalence, and mortality rates were higher than in urban areas and the disease onset occurred 10 years later. Of the risk factors examined, only agricultural work and rural residence were significant.
CONCLUSIONS: The incidence, prevalence, and mortality rates agree with those in recent Italian surveys and with most international studies, but the distribution of cases varied with higher rates in mountainous areas. Further prospective studies are required.

Entities:  

Mesh:

Year:  2003        PMID: 12601112     DOI: 10.1212/01.wnl.0000048208.54755.78

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Evaluation of occupational exposure to magnetic fields and motor neuron disease mortality in a population-based cohort.

Authors:  Lauren E Parlett; Joseph D Bowman; Edwin van Wijngaarden
Journal:  J Occup Environ Med       Date:  2011-12       Impact factor: 2.162

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 3.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

4.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

5.  Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964-1998.

Authors:  Vittorio Govoni; Enrico Granieri; Elisa Fallica; Ilaria Casetta
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

Review 6.  Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

Authors:  Christi Kolarcik; Robert Bowser
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 7.  Exercise and amyotrophic lateral sclerosis.

Authors:  J P Lopes de Almeida; R Silvestre; A C Pinto; M de Carvalho
Journal:  Neurol Sci       Date:  2012-01-07       Impact factor: 3.307

Review 8.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

Review 9.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

Review 10.  Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Jinghuan Fang; Muke Zhou; Mi Yang; Cairong Zhu; Li He
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.